March 2022

Researchers developed a model to predict when cognitively unimpaired individuals who have brain amyloidosis would develop symptoms of Alzheimer dementia using positron emission tomography scans for amyloid accumulation.
Read More

The psychedelic compound psilocybin was not more effective than the antidepressant escitalopram in reducing symptoms of depression in patients with moderate-to-severe major depressive disorder.
Read More

Initiating antiepileptic therapy in infants with tuberous sclerosis complex before their first seizure may delay the onset of seizures, according to a new study.
Read More

In a follow-up study to an intervention trial that was stopped for futility, children and adolescents with migraines showed long-lasting improvements in headache frequency regardless of their initial treatment.
Read More

Previous small studies have suggested that disability and age are associated with the severity of SARS-CoV-2 infections in patients with multiple sclerosis (MS). More detailed analysis from a larger and more diverse population would aid healthcare providers in identifying which patients require more careful monitoring.
Read More

Subscribe to
Value-Based Care in Neurology

Stay up to date with personalized medicine by subscribing to receive the free VBCN e‑Newsletter.

I'd like to receive: